Amit Jolly is a prominent figure in the biotech investment landscape, serving as a key player at Carpe Biosciences, a multibillion family office. With a focus on identifying and investing in companies spearheading innovative therapeutic solutions, Amit Jolly brings a wealth of experience in R&D and Go-To-Market strategies. His passion for enhancing patient care through cutting-edge therapies is underscored by his extensive background as a biotech therapeutics analyst, covering a wide array of disease indications. Amit's academic journey boasts impressive accolades, including a Bachelor of Science in Biotechnology, a Master of Arts in Biotechnology from Columbia University, and a high school education from The Peddie School. Amit's professional trajectory is equally remarkable, with roles at prestigious organizations such as BTIG, EY, and Velos. His diverse experience spans from being a Founder & CEO in Pharma & Digital Health Consulting to serving as a Healthcare Analyst at GlobalData's Clinical Research Investigative Reporting. Amit's commitment to the healthcare industry is evident through his various roles, including researcher positions at renowned institutions like Children's Hospital of New York and the Irving Cancer Research Center. Additionally, his involvement in community service as an E.R. Patient Care Volunteer at Centra State Medical Center further exemplifies his dedication to improving healthcare outcomes.